SGS, an analytical and bioanalytical contract services provider, has made additional investments at its lab in Fairfield, NJ, to increase services and capacity to support extractables and leachables (E&L) testing for the pharma and biopharma industries. At the company’s North American CoE for E&L, two additional instruments have been installed and validated, and SGS will hire additional analysts dedicated to these services.   The new instruments, an LC-MS/MS, and GC-MS with head-space ...